Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

View source ↗

Summary

This ClinicalTrials.gov entry reports on a study evaluating the quality of life of Fabry disease patients aged 65 and older, comparing outcomes with and without…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wladimir MAUHIN, Dr | Conditions: Fabry Disease, Aged 65 Years or Older | Status: RECRUITING